ZA882426B - Orally administrable therapeutic compositions for the reduction of beta-lactamines undesirable actions - Google Patents

Orally administrable therapeutic compositions for the reduction of beta-lactamines undesirable actions

Info

Publication number
ZA882426B
ZA882426B ZA882426A ZA882426A ZA882426B ZA 882426 B ZA882426 B ZA 882426B ZA 882426 A ZA882426 A ZA 882426A ZA 882426 A ZA882426 A ZA 882426A ZA 882426 B ZA882426 B ZA 882426B
Authority
ZA
South Africa
Prior art keywords
lactamines
beta
reduction
therapeutic compositions
orally administrable
Prior art date
Application number
ZA882426A
Inventor
Tancrede Cyrille
Andremont Antoine
Labia Roger
Leonard Florence
Original Assignee
Institut Gustave Roussy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Gustave Roussy filed Critical Institut Gustave Roussy
Publication of ZA882426B publication Critical patent/ZA882426B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA882426A 1987-04-10 1988-04-07 Orally administrable therapeutic compositions for the reduction of beta-lactamines undesirable actions ZA882426B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705110A FR2613624B1 (en) 1987-04-10 1987-04-10 ORAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITION FOR REDUCING THE EFFECTS OF B-LACTAMINES

Publications (1)

Publication Number Publication Date
ZA882426B true ZA882426B (en) 1988-09-28

Family

ID=9350003

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882426A ZA882426B (en) 1987-04-10 1988-04-07 Orally administrable therapeutic compositions for the reduction of beta-lactamines undesirable actions

Country Status (8)

Country Link
EP (1) EP0309532A1 (en)
JP (1) JPH01503537A (en)
AU (1) AU604117B2 (en)
FR (1) FR2613624B1 (en)
OA (1) OA09023A (en)
PT (1) PT87190B (en)
WO (1) WO1988007865A1 (en)
ZA (1) ZA882426B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI920206A0 (en) * 1992-01-17 1992-01-17 Pekka Untamo Heino MEDICINSK ANVAENDNING, MEDICINSKT FOERFARANDE OCH PREPARAT.
FR2843302B1 (en) 2002-08-09 2004-10-22 Centre Nat Rech Scient GALENIC FORM FOR COLLECTIVE DELIVERY OF ACTIVE PRINCIPLES
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
FI20105572A0 (en) 2010-05-24 2010-05-24 Prevab R Lcc Modified beta-lactamase and methods and uses related thereto
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
WO2015161243A2 (en) 2014-04-17 2015-10-22 Synthetic Biologics, Inc. Beta-lactamases with improved properties for therapy
CN106574273B (en) 2014-08-28 2021-07-02 合成生物制品有限公司 Coli-based production of beta-lactamases
CN107148473B (en) 2014-10-08 2021-08-06 合成生物制品有限公司 Beta-lactamase formulations and uses thereof
JP6427278B2 (en) 2014-12-23 2018-11-21 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ pirin polypeptide and immune modulation
EP3236993B1 (en) 2014-12-23 2023-09-13 Theriva Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
SI3065748T1 (en) 2014-12-23 2018-05-31 4D Pharma Research Limited A bacteroides thetaiotaomicron strain and its use in reducing inflammation
JP6810697B2 (en) 2015-02-23 2021-01-13 シンセティック・バイオロジクス・インコーポレイテッド Carbapenemase used with antibiotics to protect the intestinal microbiome
AU2016229976B2 (en) 2015-03-06 2021-11-11 Theriva Biologics, Inc. Safe and effective beta-lactamase dosing for microbiome protection
CN114984057A (en) 2015-06-15 2022-09-02 4D制药研究有限公司 Compositions comprising bacterial strains
MA41060B1 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
RS59446B1 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Blautia stercosis and wexlerae for use in treating inflammatory and autoimmune diseases
MA41010B1 (en) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprising bacterial strains
SI3360559T1 (en) 2015-06-15 2020-02-28 4D Pharma Research Limited Compositions comprising bacterial strains
EP3209310B1 (en) 2015-11-20 2018-01-31 4D Pharma Research Limited Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
NZ745678A (en) 2016-03-04 2019-03-29 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
TW201821093A (en) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 Compositions comprising bacterial strains
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
AU2018272291A1 (en) 2017-05-22 2020-01-16 4D Pharma Research Limited Compositions comprising bacterial strains
TW201907931A (en) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 Composition comprising a bacterial strain
CN111107859B (en) 2017-06-14 2022-04-29 4D制药研究有限公司 Compositions comprising bacterial strains
HUE052319T2 (en) 2017-06-14 2021-04-28 4D Pharma Res Ltd Compositions comprising bacterial strains
ES2917415T3 (en) 2017-06-14 2022-07-08 4D Pharma Res Ltd Compositions comprising a bacterial strain

Also Published As

Publication number Publication date
AU1578688A (en) 1988-11-04
PT87190A (en) 1988-05-01
PT87190B (en) 1992-08-31
AU604117B2 (en) 1990-12-06
FR2613624A1 (en) 1988-10-14
WO1988007865A1 (en) 1988-10-20
EP0309532A1 (en) 1989-04-05
JPH01503537A (en) 1989-11-30
OA09023A (en) 1991-03-31
FR2613624B1 (en) 1990-11-23

Similar Documents

Publication Publication Date Title
ZA882426B (en) Orally administrable therapeutic compositions for the reduction of beta-lactamines undesirable actions
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
IL86089A (en) Pharmaceutical compositions containing certain androstane-17-ones for the prophylaxis and therapy of retroviral infections
PT76780A (en) Process for the preparation of compositions for topical administration
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
ZA881791B (en) Therapeutic compositions
GB8713769D0 (en) Compositions of matter
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
AU3813289A (en) Treatment of gastrointestinal disorders
AU1628988A (en) Pharmaceutical compositions containing higher alcohols for the treatment of prostatic pathologies
HUT52397A (en) Orally administrable hygienic compositions
AR245125A1 (en) Procedure for the preparation of arylpiperazinyl-alkylenphenyl-p-heterocyclic compounds and their pharmaceutically acceptable salts from acid addition.
GB8715966D0 (en) Compositions of matter
EP0302263A3 (en) Therapeutic composition for combatting aids
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
IL104132A0 (en) Compositions for the treatment of mammalian diseases
GB2205313B (en) Preparation of trifluoromethyltoluene from halomethylbenzotrifluoride
GB2113998B (en) Lactitol for the treatment of liver disease
GB8705183D0 (en) Compositions of matter
GB8703068D0 (en) Compositions of matter
IL94402A0 (en) Pharmaceutical compositions containing imidazodiazepines for the treatment of neurological symptoms
IL82376A (en) Pharmaceutical composition for the treatment of inflammatory conditions
GB8324487D0 (en) Topically administrable pharmaceutical compositions
PT86527A (en) Process for the preparation of 4-arylcarbonyl-1-](4-morpholinyl)-lower-alkyl"-1h-indoles